Wang Xue-Ping, Hao Zi-Qi, Liu Ya-Lan, Mei Ling-Yun, He Chu-Feng, Niu Zhi-Jie, Sun Jie, Zhao Yu-Lin, Feng Yong
Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
Central Laboratory of Taiyuan Hospital Center, Taiyuan, Shanxin, People's Republic of China.
Biochem Biophys Res Commun. 2017 Nov 4;493(1):258-262. doi: 10.1016/j.bbrc.2017.09.034. Epub 2017 Sep 9.
Waardenburg syndrome (WS) is an autosomal dominant inherited non-syndromic type of hereditary hearing loss characterized by varying combinations of sensorineural hearing loss and abnormal pigmentation of the hair, skin, and inner ear. WS is classified into four subtypes (WS1-WS4) based on additional symptoms. WS2 is characterized by the absence of additional symptoms. Recently, we identified a SOX10 missense mutation c.422T > C (p.L141P) associated with WS2. We performed functional assays and found the mutant loses DNA-binding capacity, shows aberrant cytoplasmic and nuclear localization, and fails to interact with PAX3. Therefore, the mutant cannot transactivate the MITF promoter effectively, inhibiting melanin synthesis and leading to WS2. Our study confirmed haploinsufficiency as the underlying pathogenesis for WS2.
瓦登伯革氏综合征(WS)是一种常染色体显性遗传的非综合征型遗传性听力损失,其特征为感音神经性听力损失与头发、皮肤和内耳色素沉着异常的不同组合。根据其他症状,WS被分为四个亚型(WS1-WS4)。WS2的特征是没有其他症状。最近,我们鉴定出一个与WS2相关的SOX10错义突变c.422T>C(p.L141P)。我们进行了功能分析,发现该突变体失去了DNA结合能力,表现出异常的细胞质和细胞核定位,并且无法与PAX3相互作用。因此,该突变体不能有效地反式激活MITF启动子,抑制黑色素合成,导致WS2。我们的研究证实了单倍剂量不足是WS2的潜在发病机制。